Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta® in the prophylactic treatment of chemotherapy-induced neutropenia
Waller, C., Blakeley, C., Pennella, E., Bronchud, M.H., Mattano, L., Berzoy, O., Voitko, N., Adamchuk, H., Zautashvili, Z., Vinnyk, Y., Nemsadze, G., Dzagnidze, G., Shparyk, Y., Lytvyn, I., Rusyn, A.,Volume:
72
Langue:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(17)30217-4
Date:
February, 2017
Fichier:
PDF, 52 KB
english, 2017
File converter
Plus de résultats de recherche
More benefits 
